Vol 66, No 4 (2016)
Case report
Published online: 2016-12-23

open access

Page views 811
Article views/downloads 1673
Get Citation

Connect on Social Media

Connect on Social Media

A child with a central nervous system relapse of a facial embryonal rhabdomyosarcoma

Agata Adamczewska, Julita Janura-Szymańska, Klaudia Kończak, Wiesław Smoczyk, Miłosz Jazdon, Katarzyna Derwich
Nowotwory. Journal of Oncology 2016;66(4):322-325.

Abstract

Rhabdomyosarcoma (RMS) is the most common type of soft tissue sarcoma in children. There are two main types of RMS: embryonal and alveolar (having a worse prognosis). The treatment for childhood RMS is based on surgery, chemotherapy and radiation. In spite of very intensive therapy, 1/3 of patients suffer a relapse. The case report presents a child with facial embryonal RMS with an atypical central nervous system relapse; this, despite a comprehensive diagnostic process, was diagnosed during the autopsy.

References

  1. Okcu F, Hicks J, Horowitz M et al. Rhabdomyosarcoma in childhood and adolescence: Epidemiology, pathology, and molecular pathogenesis. http://www.uptodate.com/contents/rhabdomyosarcoma-in-childhood-and-adolescence-epidemiology-pathology-and-molecular-pathogenesis.
  2. American Cancer Society, Rhabdomyosarcoma. http://www.cancer.org/ acs/groups/cid/documents/webcontent/003136-pdf.pdf.
  3. Mazzoleni S, Bisogno G, Garaventa A, et al. Associazione Italiana di Ematologia e Oncologia Pediatrica Soft Tissue Sarcoma Committee. Outcomes and prognostic factors after recurrence in children and adolescents with nonmetastatic rhabdomyosarcoma. Cancer. 2005; 104(1): 183–190.
  4. Kazanowska B, Chybicka A. Nowotwory tkanek miękkich. http://www.sarcoma.pl/pliki/Zasady_leczenia/Miesakitkanekmiekkichmlodzi.pdf.
  5. Dantonello TM, Stark M, Timmermann B, et al. Cooperative Weichteilsarkom Studiengruppe [CWS]. Tumour volume reduction after neoadjuvant chemotherapy impacts outcome in localised embryonal rhabdomyosarcoma. Pediatr Blood Cancer. 2015; 62(1): 16–23.
  6. Chisholm JC, Marandet J, Rey A, et al. Prognostic factors after relapse in nonmetastatic rhabdomyosarcoma: a nomogram to better define patients who can be salvaged with further therapy. J Clin Oncol. 2011; 29(10): 1319–1325.
  7. Zalewska-Szewczyk B, Kazanowska B, Młynarski W, et al. The analysis of clinical course and outcome of soft tissue sarcoma in parameningeal localization in children treated according to the CWS 96 protocol — a report of the Polish Paediatric Solid Tumours Group. Contemp Oncol. 2008; 12: 116–120.
  8. España P, Chang P, Wiernik PH. Increased incidence of brain metastases in sarcoma patients. Cancer. 1980; 45(2): 377–380.
  9. Wiens AL, Hattab EM. The pathological spectrum of solid CNS metastases in the pediatric population. J Neurosurg Pediatr. 2014; 14(2): 129–135.
  10. Fusner JE, Pizzo PA, Poplack DG, et al. Meningeal relapse of orbital rhabdomyosarcoma. Med Pediatr Oncol. 1978; 4(3): 247–251.
  11. Micallef-Eynaud PD, Goulden NT, Langdale-Brown B, et al. Intracerebral recurrence of primary intrathoracic rhabdomyosarcoma. Med Pediatr Oncol. 1993; 21(2): 132–136.